Eli Lilly and Company (NYSE:LLY) had a weak trading session and its shares were last down at $74.06, down -0.19% or -0.26 points. The trading data also revealed that the total net flow stood at $44.42 million as the shares had $92.23 million in upticks but lost $47.82 million in downticks. The up/down ratio was 1.93. This data is particularly important for the traders and speculators alike as it could also be used to gauge the strength of the momentum in the shares. During the past week, the shares have seen a change of 0.15% in the shares.The block trade data suggests an inflow of $46.83 million in upticks and an outflow of $0 million in downticks. The up/down ratio for the block stood at 0. The net money flow for this transaction was recorded at $46.83.
Eli Lilly and Company has lost 0.12% in the last five trading days and dropped 3.24% in the last 4 weeks. Eli Lilly and Company is up 4.8% in the last 3-month period. Year-to-Date the stock performance stands at -11.14%.
Currently the company Insiders own 0.2% of Eli Lilly and Company shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -0.61% . Institutional Investors own 76.21% of Eli Lilly and Company shares. During last six month period, the net percent change held by insiders has seen a change of -0.63%. . On the companys insider trading activities, Barnes Melissa S, officer (Chief Eth/Cmpl Ofcr & SVP, ERM) of Lilly Eli & Co, unloaded 992 shares at an average price of $73.77 on June 10, 2016. The total amount of the transaction was worth $73,180, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Eli Lilly and Company (NYSE:LLY) witnessed a decline in the market cap on Friday as its shares dropped 0.53% or 0.39 points. After the session commenced at $74.65, the stock reached the higher end at $75.08 while it hit a low of $73.475. With the volume soaring to 6,604,924 shares, the last trade was called at $73.86. The company has a 52-week high of $92.85. The company has a market cap of $81,529 million and there are 1,103,837,000 shares in outstanding. The 52-week low of the share price is $67.88.
Eli Lilly and Company (Lilly) is engaged in drug manufacturing business. The Company discovers, develops, manufactures and market products in two segments: human pharmaceutical products and animal health products. The Companys products are sold in approximately 120 countries. The Companys human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Companys Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company manufactures and distributes its products through facilities in the United States, Puerto Rico and 11 other countries. Its products include endocrinology products, neuroscience products, oncology products, cardiovascular products, products for food animals, products for companion animals and Novartis AH products.